1. Home
  2. WIMI vs RLYB Comparison

WIMI vs RLYB Comparison

Compare WIMI & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WiMi Hologram Cloud Inc.

WIMI

WiMi Hologram Cloud Inc.

N/A

Current Price

$1.88

Market Cap

31.9M

Sector

Technology

ML Signal

N/A

Logo Rallybio Corporation

RLYB

Rallybio Corporation

N/A

Current Price

$11.11

Market Cap

28.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WIMI
RLYB
Founded
2015
2018
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.9M
28.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
WIMI
RLYB
Price
$1.88
$11.11
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
44.3K
235.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.72
EPS
N/A
N/A
Revenue
N/A
$600,000.00
Revenue This Year
N/A
$17.61
Revenue Next Year
N/A
N/A
P/E Ratio
$1.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.22
52 Week High
$7.26
$11.49

Technical Indicators

Market Signals
Indicator
WIMI
RLYB
Relative Strength Index (RSI) 43.16 91.58
Support Level N/A $0.48
Resistance Level $3.06 N/A
Average True Range (ATR) 0.14 0.81
MACD 0.04 0.41
Stochastic Oscillator 60.00 93.58

Price Performance

Historical Comparison
WIMI
RLYB

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: